UnitedHealth Group Incorporated $UNH Shares Sold by First Bank & Trust

First Bank & Trust lessened its stake in UnitedHealth Group Incorporated (NYSE:UNH) by 7.3% in the 2nd quarter, HoldingsChannel.com reports. The institutional investor owned 1,353 shares of the healthcare conglomerate’s stock after selling 106 shares during the quarter. First Bank & Trust’s holdings in UnitedHealth Group were worth $422,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors have also modified their holdings of UNH. Bayforest Capital Ltd increased its holdings in shares of UnitedHealth Group by 685.7% in the 1st quarter. Bayforest Capital Ltd now owns 55 shares of the healthcare conglomerate’s stock valued at $29,000 after acquiring an additional 48 shares during the last quarter. Clal Insurance Enterprises Holdings Ltd raised its holdings in UnitedHealth Group by 416.7% during the first quarter. Clal Insurance Enterprises Holdings Ltd now owns 62 shares of the healthcare conglomerate’s stock worth $32,000 after purchasing an additional 50 shares in the last quarter. IAG Wealth Partners LLC acquired a new position in shares of UnitedHealth Group in the 1st quarter valued at $42,000. Copia Wealth Management purchased a new stake in UnitedHealth Group in the fourth quarter valued at $42,000. Finally, O Brien Wealth Partners LLC grew its holdings in shares of UnitedHealth Group by 74.0% during the first quarter. O Brien Wealth Partners LLC now owns 87 shares of the healthcare conglomerate’s stock worth $46,000 after purchasing an additional 37 shares during the last quarter. 87.86% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

UNH has been the topic of several research analyst reports. Hsbc Global Res lowered UnitedHealth Group from a “hold” rating to a “moderate sell” rating in a research report on Wednesday, May 21st. TD Cowen downgraded shares of UnitedHealth Group from a “buy” rating to a “hold” rating and set a $308.00 price objective on the stock. in a research report on Monday, May 19th. HSBC reiterated a “reduce” rating and set a $270.00 target price (down previously from $490.00) on shares of UnitedHealth Group in a research note on Wednesday, May 21st. JPMorgan Chase & Co. decreased their price objective on UnitedHealth Group from $418.00 to $310.00 and set an “overweight” rating for the company in a research report on Wednesday, August 6th. Finally, Robert W. Baird restated an “underperform” rating and set a $198.00 price target (down previously from $312.00) on shares of UnitedHealth Group in a research note on Thursday, July 31st. Sixteen investment analysts have rated the stock with a Buy rating, six have issued a Hold rating and three have assigned a Sell rating to the company’s stock. Based on data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and a consensus target price of $358.95.

UnitedHealth Group Price Performance

UnitedHealth Group stock opened at $348.05 on Tuesday. The company has a quick ratio of 0.85, a current ratio of 0.85 and a debt-to-equity ratio of 0.73. The firm’s 50-day simple moving average is $292.87 and its 200 day simple moving average is $367.43. UnitedHealth Group Incorporated has a 52 week low of $234.60 and a 52 week high of $630.73. The firm has a market capitalization of $315.22 billion, a PE ratio of 15.08, a P/E/G ratio of 2.30 and a beta of 0.44.

UnitedHealth Group (NYSE:UNH) last announced its earnings results on Tuesday, July 29th. The healthcare conglomerate reported $4.08 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $4.45 by ($0.37). UnitedHealth Group had a return on equity of 23.32% and a net margin of 5.04%.The business had revenue of $111.62 billion for the quarter, compared to analyst estimates of $111.75 billion. During the same quarter in the previous year, the firm posted $6.80 EPS. The business’s revenue was up 12.9% on a year-over-year basis. UnitedHealth Group has set its FY 2025 guidance at 16.000- EPS. On average, equities research analysts predict that UnitedHealth Group Incorporated will post 29.54 EPS for the current fiscal year.

UnitedHealth Group Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Tuesday, September 23rd. Stockholders of record on Monday, September 15th will be issued a $2.21 dividend. This represents a $8.84 dividend on an annualized basis and a dividend yield of 2.5%. The ex-dividend date of this dividend is Monday, September 15th. UnitedHealth Group’s payout ratio is 38.30%.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.